Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success
Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer. The disease is often diagnosed after wide-spread dissemination, and the standard treatment combines aggressive surgery with platinum-based chemotherapy; however, most patients experience relapse in the form of peritoneal carcinom...
Main Authors: | Galaxia M. Rodriguez, Edward Yakubovich, Barbara C. Vanderhyden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/23/5694 |
Similar Items
-
Immunogenetic Predisposition to SARS-CoV-2 Infection
by: Claudia Lehmann, et al.
Published: (2022-12-01) -
Prediction of an immunogenic peptide ensemble and multi-subunit vaccine for Visceral leishmaniasis using bioinformatics approaches
by: Manu Kupani, et al.
Published: (2023-12-01) -
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens
by: Galaxia M. Rodriguez, et al.
Published: (2024-01-01) -
Characterization of CD8+ T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
by: Tomoyo Shinkawa, et al.
Published: (2021-01-01) -
Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment
by: Ormandjieva Anastasia
Published: (2023-08-01)